SPY
774.94
QQQ
756.43
BTC/USD
85,314.43
−0.51%
DIA
512.59
GLD
379.03
TLT
77.13
US
Sign in
Register
My Account
Benzinga
Markets & News
Markets
Stocks & Sectors
Stocks
Ratings & Research
Ratings
Trading
Trading
Screeners & Lists
Screeners
Learn
Learn
Premium
Premium Services
Markets & News
Breaking headlines, the trading day, and the calendars that move it.
Stocks & Sectors
Research any ticker, then drill into sectors, ratings, and options.
Ratings & Research
Wall Street calls, insider moves, and Benzinga's own stock rankings.
Trading
Options flow, trade calculators, and ideas for active traders.
Screeners & Lists
Filter the market your way, or start from a curated list.
Learn
Pick a broker, grow your savings, and protect what you've built.
Premium Services
Edge
Ratings, signals & screens
Pro
Real-time news & data terminal
Research
Trade alerts & newsletters
APIs
Market data licensing
All sections
IM Cannabis Corp
IMCC
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$1.91
-0.03
-1.55%
Last update: Oct 5, 7:56 PM
$1.91
-0.03
-1.55%
Get Report
Overview
News
Earnings Forecast
Financials
Sentiment
Compare
Stock Report
Privacy Manager
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga
Edge
Benzinga
Research
Benzinga
Pro
Logout
IM Cannabis Analyst Price Targets
Wall Street analyst price targets and consensus rating for IM Cannabis (IMCC).
Analyst Ratings News
PRO
Watching Cannabis Sector; Bank Of America Issues Note On Sector, Outlook For 2023
Benzinga Newsdesk
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2021
Benzinga Insights
PRO
Roth Capital Initiates Coverage On IM Cannabis with Buy Rating, Announces Price Target of $8
Roth Capital analyst Scott Fortune initiates coverage on IM Cannabis (NASDAQ:IMCC) with a Buy rating and announces Price Target of $8.
Benzinga Newsdesk
Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2021
Benzinga Insights
Benzinga's Top Ratings Upgrades, Downgrades For June 10, 2021
Benzinga Insights
PRO
Alliance Global Partners Initiates Coverage On IM Cannabis with Buy Rating, Announces Price Target of $10
Alliance Global Partners analyst Aaron Grey initiates coverage on IM Cannabis (NASDAQ:IMCC) with a Buy rating and announces Price Target of $10.
Benzinga Newsdesk
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
Eli Lilly and Co
NYSE:LLY
$1146.86
-%
Johnson & Johnson
NYSE:JNJ
$253.06
-%
Merck & Co Inc
NYSE:MRK
$139.57
-%
Novartis AG
NYSE:NVS
$140.91
-%
AstraZeneca PLC
NYSE:AZN
$157.01
-%
Novo Nordisk AS
NYSE:NVO
$37.55
-%
Pfizer Inc
NYSE:PFE
$27.43
-%
Bristol-Myers Squibb Co
NYSE:BMY
$58.8
-%
Sanofi SA
NASDAQ:SNY
$39.6
-%
GSK PLC
NYSE:GSK
$47.13
-%
Show all 10 related companies
